enVVeno Medical (NASDAQ:NVNO) Releases Earnings Results, Beats Estimates By $0.05 EPS

enVVeno Medical (NASDAQ:NVNO) released its quarterly earnings results on Thursday. The company reported ($0.30) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.35) by $0.05, Zacks reports.

enVVeno Medical Stock Performance

Shares of NVNO stock traded down $0.35 on Friday, reaching $3.18. The stock had a trading volume of 239,342 shares, compared to its average volume of 111,170. The stock has a market cap of $55.76 million, a P/E ratio of -2.47 and a beta of 1.22. enVVeno Medical has a 1 year low of $2.45 and a 1 year high of $6.97. The company has a 50 day simple moving average of $3.27 and a 200 day simple moving average of $3.70.

About enVVeno Medical

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company’s lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).